Annals of Saudi medicine
-
Annals of Saudi medicine · May 2004
Review Case ReportsCystic teratoma of the pancreas: a case report.
-
Annals of Saudi medicine · May 2004
Screening, supplements and the use of hormonal replacement therapy in postmenopausal women in a family medicine department prior to the publication of the Woman's Health Initiative report.
Many guidelines and recommendations exist on the management of the menopause. Because it is not certain what women do or what management they receive in practice, we studied what was prescribed for postmenopausal women and what screening they had undergone. ⋯ Many postmenopausal women with access to medical care were not screened nor were they taking supplements in accordance with published guidelines. There was a discrepancy in the management of Saudi and non-Saudi women that could be explained partially by the high percentage of medical professionals among non-Saudi women who are more likely to actively seek medical attention. Our study showed a large proportion of women on HRT, the standard of care before the publication of the Women's Health Initiative study.
-
Annals of Saudi medicine · May 2004
Comparative StudyDifferences between males and females in adult sickle cell pain crisis in eastern Saudi Arabia.
Sickle cell disease (SCD) is highly prevalent in the Al-Hasa area of eastern Saudi Arabia. We analyzed our patient data to try and find an explanation for the unexpected observation that more males than females with SCD were transferred to the hospital after a stay in the stabilization unit. ⋯ These preliminary observations point to the need for further studies into gender differences in pain crisis in patients with SCD.
-
Annals of Saudi medicine · May 2004
Plasma homocysteine and retinal artery occlusive disease: a case-control study.
Previous studies have documented that elevated plasma homocysteine is a risk factor for cardiovascular, cerebrovascular and peripheral vascular disease. In a case-control study, we sought to determine whether elevated homocysteine (HCY) is a risk factor for retinal artery occlusive disease PATIENTS AND METHODS. Study subjects consisted of 20 patients (12 male, 8 female) (mean age, 55.8; range 42-70 years) with clinical and objective evidence of retinal vascular occlusive disease and 20 age-matched control subjects (9 males, 11 females) (mean age, 55.3 years; range 50-68 years). Hyperhomocysteinemia was defined as a plasma HCY level >15 micromol/L by HPLC. We also measured concentrations of triglycerides, and total cholesterol, LDL cholesterol, and HDL cholesterol. ⋯ The mean plasma HCY level in the patient group was 21.23+/-9.53 micromol/L (range, 8.00-43.99 micromol/L) compared with 12.59+/-4.97 micromol/L (range, 6.38 to 22.88 micromol/L) in the control group (P<0.008). There was no correlation between HCY and serum triglycerides or cholesterol levels within each group. We conclude that high plasma HCY level may be a risk factor for retinal artery occlusive disease.